References
- Tian E, Zhan F, Walker R, . The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med2003;349:2483–2494.
- Haaber J, Abildgaard N, Knudsen LM, . Myeloma cell expression of 10 candidate genes for osteolytic bone disease. Only overexpression of DKK1 correlates with clinical bone involvement at diagnosis. Br J Haematol 2008;140:25–35.
- Giuliani N, Morandi F, Tagliaferri S, . Production of Wnt inhibitors by myeloma cells: potential effects on canonical Wnt pathway in the bone microenvironment. Cancer Res 2007;67:7665–7674.
- Zhan F, Hardin J, Kordsmeier B, . Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells. Blood 2002;99:1745–1757.
- Standal T, Abildgaard N, Fagerli UM, . HGF inhibits BMP-induced osteoblastogenesis: possible implications for the bone disease of multiple myeloma. Blood 2007;109:3024–3030.
- Holt RU, Fagerli UM, Baykov V, . Hepatocyte growth factor promotes migration of human myeloma cells. Haematologica 2008; 93:619–622.
- Otsuka T, Jakubczak J, Vieira W, . Disassociation of met-mediated biological responses in vivo: the natural hepatocyte growth factor/scatter factor splice variant NK2 antagonizes growth but facilitates metastasis. Mol Cell Biol 2000;20:2055–2065.
- Seidel C, Sundan A, Hjorth M, . Serum syndecan-1: a new independent prognostic marker in multiple myeloma. Blood 2000; 95:388–392.
- Seidel C, Borset M, Hjertner O, . High levels of soluble syndecan-1 in myeloma-derived bone marrow: modulation of hepatocyte growth factor activity. Blood 2000;96:3139–3146.
- Rasmussen T, Jensen L, Honore L, . Circulating clonal cells in multiple myeloma do not express CD34 mRNA, as measured by single-cell and real-time RT-PCR assays. Br J Haematol 1999;107: 818–824.
- Cumova J, Kovarova L, Potacova A, . Optimization of immunomagnetic selection of myeloma cells from bone marrow using magnetic activated cell sorting. Int J Hematol 2010;92:314–319.
- Theilgaard-Monch K, Cowland J, Borregaard N. Profiling of gene expression in individual hematopoietic cells by global mRNA amplification and slot blot analysis. J Immunol Methods 2001;252: 175–189.
- Kaiser M, Mieth M, Liebisch P, . Serum concentrations of DKK-1 correlate with the extent of bone disease in patients with multiple myeloma. Eur J Haematol 2008;80:490–494.
- Terpos E, Christoulas D, Katodritou E, . Elevated circulating sclerostin correlates with advanced disease features and abnormal bone remodeling in symptomatic myeloma: reduction post-bortezomib monotherapy. Int J Cancer2011 Nov 2. [Epub ahead of print]